169 related articles for article (PubMed ID: 29860264)
1. Elevated Transient Receptor Potential Melastatin 8 (TRPM8) Expression Is Correlated with Poor Prognosis in Pancreatic Cancer.
Du JD; Zheng X; Chen YL; Huang ZQ; Cai SW; Jiao HB; Zhu ZM; Hu B
Med Sci Monit; 2018 Jun; 24():3720-3725. PubMed ID: 29860264
[TBL] [Abstract][Full Text] [Related]
2. Over-expression of TRPM8 is associated with poor prognosis in urothelial carcinoma of bladder.
Xiao N; Jiang LM; Ge B; Zhang TY; Zhao XK; Zhou X
Tumour Biol; 2014 Nov; 35(11):11499-504. PubMed ID: 25128062
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression of growth-regulated oncogene-alpha in tumor and stromal cells predicts unfavorable prognosis in pancreatic cancer.
Lian S; Zhai X; Wang X; Zhu H; Zhang S; Wang W; Wang Z; Huang J
Medicine (Baltimore); 2016 Jul; 95(30):e4328. PubMed ID: 27472713
[TBL] [Abstract][Full Text] [Related]
4. Over-Expression of Alpha-Enolase as a Prognostic Biomarker in Patients with Pancreatic Cancer.
Sun L; Guo C; Cao J; Burnett J; Yang Z; Ran Y; Sun D
Int J Med Sci; 2017; 14(7):655-661. PubMed ID: 28824297
[No Abstract] [Full Text] [Related]
5. TRPM8 Ion Channels as Potential Cancer Biomarker and Target in Pancreatic Cancer.
Yee NS
Adv Protein Chem Struct Biol; 2016; 104():127-155. PubMed ID: 27038374
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of TRPM7 is associated with poor prognosis in human ovarian carcinoma.
Wang J; Xiao L; Luo CH; Zhou H; Hu J; Tang YX; Fang KN; Zhang Y
Asian Pac J Cancer Prev; 2014; 15(9):3955-8. PubMed ID: 24935580
[TBL] [Abstract][Full Text] [Related]
7. High Expression of Cell Division Cycle 42 Promotes Pancreatic Cancer Growth and Predicts Poor Outcome of Pancreatic Cancer Patients.
Yang D; Zhang Y; Cheng Y; Hong L; Wang C; Wei Z; Cai Q; Yan R
Dig Dis Sci; 2017 Apr; 62(4):958-967. PubMed ID: 28181096
[TBL] [Abstract][Full Text] [Related]
8. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
9. Silencing of TRPM8 inhibits aggressive tumor phenotypes and enhances gemcitabine sensitivity in pancreatic cancer.
Liu J; Hu G; Gong Y; Yu Q; He B; Li W; He Z; Hao W; He Z; Liu Y
Pancreatology; 2018 Dec; 18(8):935-944. PubMed ID: 30316690
[TBL] [Abstract][Full Text] [Related]
10. Transient receptor potential channel TRPM8 is over-expressed and required for cellular proliferation in pancreatic adenocarcinoma.
Yee NS; Zhou W; Lee M
Cancer Lett; 2010 Nov; 297(1):49-55. PubMed ID: 20605675
[TBL] [Abstract][Full Text] [Related]
11. Correlation of miR-494 expression with tumor progression and patient survival in pancreatic cancer.
Ma YB; Li GX; Hu JX; Liu X; Shi BM
Genet Mol Res; 2015 Dec; 14(4):18153-9. PubMed ID: 26782462
[TBL] [Abstract][Full Text] [Related]
12. Correlation and prognostic significance of MMP-2 and TFPI-2 differential expression in pancreatic carcinoma.
Zhai LL; Cai CY; Wu Y; Tang ZG
Int J Clin Exp Pathol; 2015; 8(1):682-91. PubMed ID: 25755762
[TBL] [Abstract][Full Text] [Related]
13. Latent Transforming Growth Factor β Binding Protein 2 (LTBP2) as a Novel Biomarker for the Diagnosis and Prognosis of Pancreatic Carcinoma.
Wang C; Wang G; Zhang L; Pan J; Wei Y
Med Sci Monit; 2017 Jul; 23():3232-3239. PubMed ID: 28669978
[TBL] [Abstract][Full Text] [Related]
14. Elevated expression of HABP1 is a novel prognostic indicator in triple-negative breast cancers.
Wang J; Song Y; Liu T; Shi Q; Zhong Z; Wei W; Huang S; Pang D
Tumour Biol; 2015 Jun; 36(6):4793-9. PubMed ID: 25794640
[TBL] [Abstract][Full Text] [Related]
15. miR-21 predicts poor prognosis in patients with osteosarcoma.
Ren X; Shen Y; Zheng S; Liu J; Jiang X
Br J Biomed Sci; 2016 Oct; 73(4):158-162. PubMed ID: 27922432
[TBL] [Abstract][Full Text] [Related]
16. Expression and clinical significance of HSPA2 in pancreatic ductal adenocarcinoma.
Zhang H; Gao H; Liu C; Kong Y; Wang C; Zhang H
Diagn Pathol; 2015 Mar; 10():13. PubMed ID: 25890028
[TBL] [Abstract][Full Text] [Related]
17. FoxQ1 is a Novel Molecular Target for Pancreatic Cancer and is Associated with Poor Prognosis.
Zhan HX; Xu JW; Wang L; Wu D; Zhang GY; Hu SY
Curr Mol Med; 2015; 15(5):469-77. PubMed ID: 26122655
[TBL] [Abstract][Full Text] [Related]
18. TRPM8 ion channel is aberrantly expressed and required for preventing replicative senescence in pancreatic adenocarcinoma: potential role of TRPM8 as a biomarker and target.
Yee NS; Brown RD; Lee MS; Zhou W; Jensen C; Gerke H; Yee RK
Cancer Biol Ther; 2012 Jun; 13(8):592-9. PubMed ID: 22555807
[TBL] [Abstract][Full Text] [Related]
19. G-protein-coupled receptor kinase 2 in pancreatic cancer: clinicopathologic and prognostic significance.
Zhou L; Wang MY; Liang ZY; Zhou WX; You L; Pan BJ; Liao Q; Zhao YP
Hum Pathol; 2016 Oct; 56():171-7. PubMed ID: 27346572
[TBL] [Abstract][Full Text] [Related]
20. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
